Tuesday, 21 July 2020
New online tool to fill information gaps in substandard and falsified medicines
A major challenge in preventing, detecting and responding to substandard and falsified (SF) medical products is the lack of accessible and reliable information on how widespread the problem is and where. SF medical products, which includes medicines, vaccines, diagnostic tests and devices, pose an i...
Wednesday, 15 July 2020
COVID-19 Data Platform Data Access Committee - call for nominations
Nominations for members of the COVID-19 Data Platform Data Access Committee are now open. Please consider nominating individuals to contribute expertise to this pioneering collaboration in COVID-19 and emerging infections research to email@example.com by 31 July 2020.
Wednesday, 17 June 2020
Tribute to Professor Marleen Boelaert
It is with great sadness that IDDO has learnt of the passing of Professor Marleen Boelaert, a valued member of the IDDO team since 2017. Professor Boelaert’s research concentrated on the control of tropical infectious diseases, mainly leishmaniasis and sleeping sickness.
Wednesday, 3 June 2020
More time to comment on draft Research Agenda
IDDO has extended the feedback period on its draft Research Agenda on schistosomiasis and soil-transmitted helminthiases (STHs) until July 17. Comments are welcome from the wider research community to help form the direction of research work using IDDO’s schistosomiasis and STHs data platform.
Friday, 22 May 2020
New global collaboration developing standards for standardised data collection across the VL research community
Visceral leishmaniasis (VL), also known as kala-azar, is transmitted to humans through the bites from infected female phlebotomine sand flies. If left untreated, it is fatal in 95% of cases. Globally, it is estimated there are up to 22,000 new cases of VL each year which occur in Brazil, Ethiopia, I...
Wednesday, 29 April 2020
New evidence for optimising malaria treatment in pregnant women
The research, published today in The Lancet Infectious Diseases is the fruit of joint project between investigators from around the world to conduct the largest individual patient data meta-analysis to date under the WWARN umbrella. The study found that artemether-lumefantrine (AL) and other artemis...
Thursday, 9 April 2020
Global call for strategic planning for COVID-19 medical products
Global health experts have united in a call for governments and international organisations around the world to plan strategically for the coordinated production, equitable distribution and surveillance of COVID-19 medical products to ensure access to quality-assured medications for everyone.
Thursday, 2 April 2020
Coalition launched to accelerate research on the prevention and treatment of COVID-19 in low- and middle-income countries
A group of scientists, physicians, funders, and policy makers from over 70 institutions from over 30 countries have launched an international coalition to respond to COVID-19 in resource-poor settings. The COVID-19 Clinical Research Coalition aims to accelerate desperately needed COVID-19 research i...
Monday, 30 March 2020
First global tool to track news reports of substandard and falsified medical products is live
The problem of substandard and falsified (SF) medical products affects all countries but few regulatory authorities or pharmaceutical companies have policies of publicly releasing data.
Wednesday, 11 March 2020
Triple drug combinations effective against drug-resistant malaria
12 March 2020, Bangkok (Thailand) – Adding a third antimalarial drug to current artemisinin-combination therapies (ACTs) provides effective treatment against multidrug-resistant falciparum malaria in Southeast Asia, say Mahidol and Oxford University researchers in a study published today in The Lanc...
Monday, 9 March 2020
An interview with Professor Simon Croft
Simon Croft, Professor of Parasitology at the London School of Hygiene and Tropical Medicine, has been involved in visceral leishmaniasis research for 38 years. Prof Croft has been instrumental in setting up the IDDO’s visceral leishmaniasis data platform, including serving as the Chair of its Scien...
Monday, 2 March 2020
Dépôt de demandes d’accès aux données sur la plate-forme de données Ebola
Il est désormais possible de déposer des demandes d'accès aux données sur la plate-forme de données Ebola. La plate-forme détient actuellement, sous l'autorité des gouvernements, ministères et organisations des pays touchés par le virus Ebola, des données concernant plus de 13 500 patients. Et ce no...
Monday, 2 March 2020
Ebola Data Platform open for applications to access data
The Ebola Data Platform is now open for data access applications. The platform currently holds contributed data from >13,500 patients under the authority of governments, ministries, and organisations in Ebola-affected countries, and this number is increasing. Researchers can apply to access the d...